These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 22843880)
1. β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Lee RX; Li QQ; Reed E Anticancer Res; 2012 Aug; 32(8):3103-13. PubMed ID: 22843880 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells. Li QQ; Lee RX; Liang H; Zhong Y; Reed E Med Oncol; 2013 Mar; 30(1):424. PubMed ID: 23277286 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Li X; Wang G; Zhao J; Ding H; Cunningham C; Chen F; Flynn DC; Reed E; Li QQ Cell Mol Life Sci; 2005 Apr; 62(7-8):894-904. PubMed ID: 15868412 [TBL] [Abstract][Full Text] [Related]
4. β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas. Li QQ; Wang G; Liang H; Li JM; Huang F; Agarwal PK; Zhong Y; Reed E Anticancer Res; 2013 Apr; 33(4):1421-8. PubMed ID: 23564782 [TBL] [Abstract][Full Text] [Related]
5. Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs. Li QQ; Wang G; Huang F; Li JM; Cuff CF; Reed E Med Oncol; 2013 Mar; 30(1):488. PubMed ID: 23397083 [TBL] [Abstract][Full Text] [Related]
6. β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK. Li QQ; Lee RX; Liang H; Wang G; Li JM; Zhong Y; Reed E Int J Oncol; 2013 Sep; 43(3):721-8. PubMed ID: 23817665 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy. Li QQ; Wang G; Reed E; Huang L; Cuff CF Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):868-76. PubMed ID: 22545969 [TBL] [Abstract][Full Text] [Related]
8. β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells. Zou B; Li QQ; Zhao J; Li JM; Cuff CF; Reed E Anticancer Res; 2013 Mar; 33(3):929-40. PubMed ID: 23482764 [TBL] [Abstract][Full Text] [Related]
9. Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells. Li B; Gao Y; Rankin GO; Rojanasakul Y; Cutler SJ; Tu Y; Chen YC Cancer Lett; 2015 Jan; 356(2 Pt B):418-33. PubMed ID: 25304379 [TBL] [Abstract][Full Text] [Related]
10. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species. Yang YI; Kim JH; Lee KT; Choi JH Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308 [TBL] [Abstract][Full Text] [Related]
11. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation. Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736 [TBL] [Abstract][Full Text] [Related]
13. Chloroquine reverses chemoresistance via upregulation of p21 Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Wang G; Li X; Huang F; Zhao J; Ding H; Cunningham C; Coad JE; Flynn DC; Reed E; Li QQ Cell Mol Life Sci; 2005 Apr; 62(7-8):881-93. PubMed ID: 15868411 [TBL] [Abstract][Full Text] [Related]
15. An ATF Zhai B; Chen P; Wang W; Liu S; Feng J; Duan T; Xiang Y; Zhang R; Zhang M; Han X; Chen X; Li Q; Li G; Liu Y; Huang X; Zhang W; Pan T; Yan L; Jin T; Xie T; Sui X Cancer Biol Med; 2020 Aug; 17(3):676-692. PubMed ID: 32944399 [No Abstract] [Full Text] [Related]
16. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719 [TBL] [Abstract][Full Text] [Related]
17. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1. Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213 [TBL] [Abstract][Full Text] [Related]
18. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E; Mills GB; Tsang BK Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739 [TBL] [Abstract][Full Text] [Related]
19. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression. Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490 [TBL] [Abstract][Full Text] [Related]
20. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein]. Li Y; Mi C Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]